Establishment and characterization of a Madin-Darby canine kidney reporter cell line for influenza A virus assays

Journal of Clinical Microbiology

Volumn 48, Issue 7, 2010, Pages 2515-2523

  Hossain, M Jaber ^a   Perez, Sandra ^a,b   Guo, Zhu ^a   Chen, Li Mei ^a   Donis, Ruben O ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; DNA DIRECTED RNA POLYMERASE; LUCIFERASE; ANTIVIRUS AGENT; DNA DIRECTED DNA POLYMERASE BETA; RENILLA LUCIFERIN 2 MONOOXYGENASE; VIRUS ANTIBODY;

ANIMAL CELL; ARTICLE; ASSAY; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN ADENOVIRUS 5; HUMAN CELL; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS B; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; VIRUS DETECTION; VIRUS ISOLATION; VIRUS STRAIN; ANIMAL; DOG; DRUG EFFECTS; GENETICS; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; PHYSIOLOGY; PROCEDURES; PROMOTER REGION; SERODIAGNOSIS; VIROLOGY;

HUMAN ADENOVIRUS TYPE 5; INFLUENZA A VIRUS; INFLUENZA B VIRUS; MUSTELA; ORTHOMYXOVIRIDAE;

ANIMALS; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; CELL LINE; DNA POLYMERASE I; DOGS; GENES, REPORTER; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; LUCIFERASES, RENILLA; NEUTRALIZATION TESTS; PROMOTER REGIONS, GENETIC; VIROLOGY;

EID: 77954441616     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02286-09     Document Type: Article

References (50)

1. Barenfanger, J., C. Drake, T. Mueller, T. Troutt, J. O'Brien, and K. Guttman. 2001. R-Mix cells are faster, at least as sensitive and marginally more costly than conventional cell lines for the detection of respiratory viruses. J. Clin. Virol. 22:101-110.
2. Centers for Disease Control and Prevention. 2008. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine - Marshfield, Wisconsin, 2007-08 influenza season. MMWR Morb. Mortal. Wkly. Rep. 57:393-398.
3. Chakraverty, P. 1971. Antigenic relationship between influenza B viruses. Bull. World Health Organ. 45:755-766.
4. Deyde, V. M., M. Okomo-Adhiambo, T. G. Sheu, T. R. Wallis, A. Fry, N. Dharan, A. I. Klimov, and L. V. Gubareva. 2009. Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses. Antiviral Res. 81:16-24.
5. Dharan, N. J., L. V. Gubareva, J. J. Meyer, M. Okomo-Adhiambo, R. C. McClinton, S. A. Marshall, K. St. George, S. Epperson, L. Brammer, A. I. Klimov, J. S. Bresee, and A. M. Fry. 2009. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 301:1034-1041.
6. Doller, G., W. Schuy, K. Y. Tjhen, B. Stekeler, and H. J. Gerth. 1992. Direct detection of influenza virus antigen in nasopharyngeal specimens by direct enzyme immunoassay in comparison with quantitating virus shedding. J. Clin. Microbiol. 30:866-869.
7. Fodor, E., D. C. Pritlove, and G. G. Brownlee. 1994. The influenza virus panhandle is involved in the initiation of transcription. J. Virol. 68:4092-4096. (Pubitemid 24177444)
8. Fong, C. K., M. K. Lee, and B. P. Griffith. 2000. Evaluation of R-Mix FreshCells in shell vials for detection of respiratory viruses. J. Clin. Microbiol. 38:4660-4662.
9. Gubareva, L. V., R. G. Webster, and F. G. Hayden. 2002. Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay. Antiviral Res. 53:47-61.
10. Hay, A. J., A. R. Douglas, D. B. Sparrow, K. R. Cameron, and J. J. Skehel. 1994. Antigenic and genetic characterization of current influenza strains. Eur. J. Epidemiol. 10:465-466.
11. Hughes, P., D. Marshall, Y. Reid, H. Parkes, and C. Gelber. 2007. The costs of using unauthenticated, over-passaged cell lines: how much more data do we need? Biotechniques 43:575, 577-578, 581-582.
12. Johnson, N. P., and J. Mueller. 2002. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull. Hist. Med. 76:105-115.
13. Klenk, H. D., R. Rott, M. Orlich, and J. Blodorn. 1975. Activation of influenza A viruses by trypsin treatment. Virology 68:426-439.
14. Landry, M. L., and D. Ferguson. 2003. Suboptimal detection of influenza virus in adults by the Directigen Flu A+B enzyme immunoassay and correlation of results with the number of antigen-positive cells detected by cytospin immunofluorescence. J. Clin. Microbiol. 41:3407-3409.
15. Laplante, J. M., S. A. Marshall, M. Shudt, T. T. Van, E. S. Reisdorf, L. A. Mingle, P. A. Shult, and K. St. George. 2009. Influenza antiviral resistance testing in New York and Wisconsin, 2006-2008: methodology and surveillance data. J. Clin. Microbiol. 47:1372-1378.
16. LaSala, P. R., K. K. Bufton, N. Ismail, and M. B. Smith. 2007. Prospective comparison of R-mix shell vial system with direct antigen tests and conventional cell culture for respiratory virus detection. J. Clin. Virol. 38:210-216.
17. Lazarowitz, S. G., and P. W. Choppin. 1975. Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology 68:440-454.
18. Leland, D. S., and C. C. Ginocchio. 2007. Role of cell culture for virus detection in the age of technology. Clin. Microbiol. Rev. 20:49-78.
19. Li, X., and P. Palese. 1992. Mutational analysis of the promoter required for influenza virus virion RNA synthesis. J. Virol. 66:4331-4338.
20. Lo, M. K., M. Tilgner, and P. Y. Shi. 2003. Potential high-throughput assay for screening inhibitors of West Nile virus replication. J. Virol. 77:12901-12906.
21. Lutz, A., J. Dyall, P. D. Olivo, and A. Pekosz. 2005. Virus-inducible reporter genes as a tool for detecting and quantifying influenza A virus replication. J. Virol. Methods 126:13-20.
22. Luytjes, W., M. Krystal, M. Enami, J. D. Pavin, and P. Palese. 1989. Amplification, expression, and packaging of foreign gene by influenza virus. Cell 59:1107-1113.
23. Maassab, H. F., T. Francis, Jr., F. M. Davenport, A. V. Hennessy, E. Minuse, and G. Anderson. 1969. Laboratory and clinical characteristics of attenuated strains of influenza virus. Bull. World Health Organ. 41:589-594.
24. Mills, R. D., K. J. Cain, and G. L. Woods. 1989. Detection of influenza virus by centrifugal inoculation of MDCK cells and staining with monoclonal antibodies. J. Clin. Microbiol. 27:2505-2508.
25. Murakami, S., T. Horimoto, S. Yamada, S. Kakugawa, H. Goto, and Y. Kawaoka. 2008. Establishment of canine RNA polymerase I-driven reverse genetics for influenza A virus: its application for H5N1 vaccine production. J. Virol. 82:1605-1609.
26. Neumann, G., and G. Hobom. 1995. Mutational analysis of influenza virus promoter elements in vivo. J. Gen. Virol. 76:1709-1717.
27. Olivo, P. D. 1996. Transgenic cell lines for detection of animal viruses. Clin. Microbiol. Rev. 9:321-334.
28. Olivo, P. D., P. L. Collins, M. E. Peeples, and S. Schlesinger. 1998. Detection and quantitation of human respiratory syncytial virus (RSV) using minigenome cDNA and a Sindbis virus replicon: a prototype assay for negativestrand RNA viruses. Virology 251:198-205.
29. Olivo, P. D., I. Frolov, and S. Schlesinger. 1994. A cell line that expresses a reporter gene in response to infection by Sindbis virus: a prototype for detection of positive strand RNA viruses. Virology 198:381-384. (Pubitemid 124018799)
30. Palese, P. 2006. Making better influenza virus vaccines? Emerg. Infect. Dis. 12:61-65.
31. Palese, P., and J. L. Schulman. 1976. Mapping of the influenza virus genome: identification of the hemagglutinin and the neuraminidase genes. Proc. Natl. Acad. Sci. U. S. A. 73:2142-2146.
32. Pasick, J. 2008. Advances in the molecular based techniques for the diagnosis and characterization of avian influenza virus infections. Transbound. Emerg. Dis. 55:329-338.
33. Perez, D. R., and R. O. Donis. 2001. Functional analysis of PA binding by influenza a virus PB1: effects on polymerase activity and viral infectivity. J. Virol. 75:8127-8136.
34. Piccone, M. E., A. Fernandez-Sesma, and P. Palese. 1993. Mutational analysis of the influenza virus vRNA promoter. Virus Res. 28:99-112.
35. Reina, J., V. Fernandez-Baca, I. Blanco, and M. Munar. 1997. Comparison of Madin-Darby canine kidney cells (MDCK) with a green monkey continuous cell line (Vero) and human lung embryonated cells (MRC-5) in the isolation of influenza A virus from nasopharyngeal aspirates by shell vial culture. J. Clin. Microbiol. 35:1900-1901.
36. Rowe, T., R. A. Abernathy, J. Hu-Primmer, W. W. Thompson, X. Lu, W. Lim, K. Fukuda, N. J. Cox, and J. M. Katz. 1999. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 37:937-943.
37. Smith, T. F., and L. Reichrath. 1974. Comparative recovery of 1972-1973 influenza virus isolates in embryonated eggs and primary rhesus monkey kidney cell cultures after one freeze-thaw cycle. Am. J. Clin. Pathol. 61:579-584.
38. Suarez, D. L., A. Das, and E. Ellis. 2007. Review of rapid molecular diagnostic tools for avian influenza virus. Avian Dis. 51:201-208.
39. Swenson, S. L., L. L. Vincent, B. M. Lute, B. H. Janke, K. E. Lechtenberg, J. G. Landgraf, B. J. Schmitt, D. R. Kinker, and J. K. McMillen. 2001. A comparison of diagnostic assays for the detection of type A swine influenza virus from nasal swabs and lungs. J. Vet. Diagn. Invest. 13:36-42.
40. Taubenberger, J. K., and S. P. Layne. 2001. Diagnosis of influenza virus: coming to grips with the molecular era. Mol. Diagn. 6:291-305.
41. Terenzi, F., M. J. deVeer, H. Ying, N. P. Restifo, B. R. Williams, and R. H. Silverman. 1999. The antiviral enzymes PKR and RNase L suppress gene expression from viral and non-viral based vectors. Nucleic Acids Res. 27:4369-4375.
42. Thompson, W. W., L. Comanor, and D. K. Shay. 2006. Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J. Infect. Dis. 194(Suppl. 2):S82-S91.
43. Tobita, K., A. Sugiura, C. Enomote, and M. Furuyama. 1975. Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med. Microbiol. Immunol. (Berl.) 162:9-14.
44. Tsukamoto, K., H. Ashizawa, K. Nakanishi, N. Kaji, K. Suzuki, M. Okamatsu, S. Yamaguchi, and M. Mase. 2008. Subtyping of avian influenza viruses H1 to H15 on the basis of hemagglutinin genes by PCR assay and molecular determination of pathogenic potential. J. Clin. Microbiol. 46:3048-3055.
45. Wang, Z., and G. M. Duke. 2007. Cloning of the canine RNA polymerase I promoter and establishment of reverse genetics for influenza A and B in MDCK cells. Virol. J. 4:102.
46. WHO. 2009. New influenza A (H1N1) virus: WHO guidance on public health measures, 11 June 2009. Wkly. Epidemiol. Rec. 84:261-264.
47. WHO. 2002. WHO manual on animal influenza diagnosis and surveillance. http://www.wpro.who.int/NR/rdonlyres/EFD2B9A7-2265-4AD0-BC98-97937B4FA83C/0/ manualonanimalaidiagnosisandsurveillance.pdf.
48. WHO. March 2003, posting date. World Health Organization WHO fact sheet 211. Influenza, 2003. http://www.who.int/mediacentre/factsheets/fs211/en/.
49. Wright, K. E., G. A. Wilson, D. Novosad, C. Dimock, D. Tan, and J. M. Weber. 1995. Typing and subtyping of influenza viruses in clinical samples by PCR. J. Clin. Microbiol. 33:1180-1184.
50. Yamanaka, K., N. Ogasawara, H. Yoshikawa, A. Ishihama, and K. Nagata. 1991. In vivo analysis of the promoter structure of the influenza virus RNA genome using a transfection system with an engineered RNA. Proc. Natl. Acad. Sci. U. S. A. 88:5369-5373.